IS:LALPATHLAB Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company offers a range of diagnostic and related healthcare tests and services for use in core testing and patient diagnosis, as well as in the prevention, monitoring, and treatment of disease and other health conditions. Its customers include individual patients, hospitals, other healthcare providers, and corporate customers. As of March 31, 2017, the company owned and operated a National Reference Laboratory in New Delhi, as well as 188 other clinical laboratories, 1,759 patient service centers, and approximately 5,021 pickup points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurgaon, India.

3,013.50 INR
As of 01/21/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  India
Country of incorporation:  India
IPO date:  12/23/2015
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   251,159,838,720 INR
Current dividend yield:   0.46%
Sedol:      BYY2W03

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy